Advanced Genetically Engineered Mouse Services
Supporting successful drug discovery with precision disease model mice.
Why Choose GEMCRO?
Researcher-Centric Partner
We don't just supply mice; we collaborate. From production management to consulting, we offer the value you need as a fellow researcher.
Top-Tier Expertise
With over 30 years of dedication and world-class CRISPR technology, we have developed over 200 custom models for global researchers.
View Client Publications →Global Supply Network
We supply our extensive catalog of disease models or newly customized GEMs internationally as frozen embryos or frozen sperm.
Our Services
Custom Model Generation
Bespoke development of new GEM models tailored to your specific
requirements.
All custom models can be supplied internationally as frozen sperm or
frozen embryos.
cKO
Conditional KnockoutTarget gene deletion in specific tissues or timeframes using the Cre-loxP system. Ideal for studying genes essential for embryonic development.
KI
Knock InInsert specific DNA sequences or mutations into the genome. Used for disease mutation modeling and reporter systems.
KO
Knock OutComplete removal of target genes to study their function. Efficiently produced using advanced CRISPR/Cas9 technology.
Targeted TG
Targeted TransgenicPrecise knock-in of transgenes into safe harbor loci (e.g., Rosa26, H11) for stable and predictable expression, overcoming the limitations of random insertion.
Ready-to-Use Models
Established disease models rapidly available for international supply.
Provided as frozen embryos or sperm to institutions capable of performing Embryo
Transfer (ET) and In Vitro Fertilization (IVF).
N2G Mice
ImmunodeficientHighly immunodeficient mice lacking mature T, B, and NK cells. The premier model for human cell and tissue engraftment (CDX/PDX) and oncology research.
View Publication →hiFcRn Mice
HumanizedHumanized FcRn models essential for evaluating the pharmacokinetics (PK) and half-life of human IgG antibodies and Fc-fusion therapeutics in vivo.
View Publication →hiACE2 Mice
HumanizedHumanized ACE2 models expressing the human ACE2 receptor. A critical and proven platform for SARS-CoV-2 (COVID-19) infectious disease pathogenesis and therapeutic research.
View Publication →Disease Models
Frozen ResourcesExtensive catalog of ready-to-use disease models. Available for rapid global distribution entirely frozen (embryos/sperm) to ensure genetic stability.
View GEM List →Strategic Partnerships for CROs
& Commercialization
Looking to develop proprietary models for commercial use or require specialized support for your CRO pipeline? We offer exclusive collaborative development and out-licensing opportunities tailored to your enterprise needs.
Discuss Partnership →How It Works
A transparent, step-by-step pipeline from initial consultation to successful global delivery.
Custom Model Generation
1. Consultation
In-depth discussion of research goals.
Email us to inquire →
2. Design & Vector
Validation of sgRNA/Cas9 off-target effects and precise donor vector construction.
3. Generation
Microinjection, embryo transfer, and rigorous founder genotyping via PCR/Sequencing.
4. Global Transfer
Secure cryogenic freezing (embryos/sperm) and international shipping to your facility.
Uncompromising Quality Control
Ensuring the genetic integrity and health status of your vital research models.
-
Strict SPF Facility Management
All operations are conducted inside state-of-the-art Specific Pathogen Free (SPF) barriers. Environmental parameters and microbiological monitoring are strictly enforced to international standards.
-
Rigorous Genotyping Validation
Every generated model undergoes comprehensive genetic validation. We strictly ensure that only offspring confirmed via PCR and Sanger sequencing from the F1 generation onwards are authorized for release.
-
Cryopreservation Viability
Frozen embryos and sperm utilized for global transfer are subject to strictly controlled freeze-thaw recovery tests, verifying high viability rates prior to shipment authorization.
Scientific Leadership
World-class expertise driving innovation and uncompromising quality in every GEM project.
Han-Woong Lee PhD
CEO & R&D Director- Distinguished Professor Emeritus, Yonsei Univ
- Former President of Korean Association of Laboratory Animal Science (KALAS)
- Former Professor of Seoul Natl Univ Coll of Med, Sungkyunkwan Univ Sch of Med, and Yonsei Univ
- Ph.D., Postdoc, & Res Associate, Albert Einstein Coll of Med
Jae Hoon Lee PhD
COO & Operating Director- Postdoc & Research Professor, Yonsei Univ
- Ph.D., Sungkyunkwan Univ School of Medicine
- B.S., Sungkyunkwan Univ
Yonghwan Kim PhD
CSO- Professor, Sookmyung Women's Univ
- Director, Natl Res Foundation Core Facility Support Center (Ministry of Education)
- Postdoc, Rockefeller Univ
- Ph.D., Univ. of Texas
Su Cheong Yeom DVM, PhD
Head of GEM Division- Professor, Seoul National Univ
- Director, Natl Rodent Resources Res Ctr
- Chair, Korea Genome Editing Res Initiative
- B.S., D.V.M., Ph.D. & Postdoc., Seoul Natl Univ
